Overview: With investment levels in rare & ultra-rare diseases increasing, are they all attractive for biotechs & venture capital? What factors are executives & investors...
For more than 20 years, the BIO CEO & Investor Conference has fueled biotech industry networking with premier investor and banking communities, focused on established...
The National Forum on COVID-19 Vaccine is a virtual event that will unite representatives from across the US government, with tribal, state, local, and territorial...
Expanding the mechanisms for administering therapeutics and vaccines may have the potential to disrupt the status quo and improve availability and accessibility of therapeutic and...
Are you looking for non-dilutive funding to advance your research? Join the National Institutes of Health’s National Institute on Aging (NIA) Office of Small Business...
Meet with students in a virtual booth that mimics a live career fair! We will guide you through setting up your booth, managing appointments and...
At the peak of the COVID-19 pandemic, the nation experienced a severe shortage of personal protective equipment (PPE) which threatened the safety of healthcare workers...
COVID-19 treatments exemplify the significance of the public-private sector R&D continuum. While these treatments have not generally received the same level of attention as vaccines,...
Oncology is one of the most challenging areas for research and development, but there are critical junctures where the right environment is crucial for success...
Despite COVID -19, 2020 was a remarkable year for venture fundraising and investment in healthcare. Strong exits propelled a fourth straight record year in venture...